1Marceau P, Biron S, Hould F S, et al. Liver pathology andthe metabolic syndrome X in severe obesity[J].J Clin Endocrinol Metab,1999,84:1513-1517.
2Kawasaki T, Hashimoto N. The relationship between fattyliver and hyperinsulinemia in obese Japanese children[J].J PediatrGastroenterol Nutr,1997,24:317-321.
3Knobler H, Schattner A, Zhornicki T, et al. Fatty liver-an additional and treatable feature of the insulin resistance syndrome[J].Q J Med,1999,92:73-79.
4Lee J H, Rhee P L, Lee J K, et al. Role ofhyperinsulinemia and glucose intolerance in the pathogenesis of nonalcoholicfatty liver in patients with normal body weight[J].Korean J Intern Med,1998,13:12-14.
5Sanyal A J,Campbell Sarget C,Mirshahi F,et al.Nonalcoholicsteatohepatitis: association of insulin resistance and mitochondrial abnormalities[J].Gastroenterology,2001,120:1183-1192.
6Scheen A J, Lefebvre P J. Insulin action in man[J].Diabetes Metab,1996,22:105-110.
7Day C P, James O F W. Steatohepatitis: A tale of two ‘hit'?[J].Gastroenterology,1998,114:842-845.
8Valenti L, Fracanzani A L, Dongiovanni P, et al.Tumornecrosis factor alpha promoter polymorphisms and insulin resistance innonalcoholic fatty liver disease[J].Gasteroenterology,2002,122:274-280.
9McClain C J, Barve S, Deaciue I, et al. Cytokines inalcoholic liver disease[J].Semin Liver Dis,1999,19:205-219.
10George D K, Goldwurn S, MacDonald G A, et al. Increased hepaticiron concentration in nonalcoholic steatohepatitis is associated withincreased fibrosis[J].Gastroenterology,1998,114:311-318.
